Cargando…

Is transforming growth factor beta signalling required for breast cancer metastatic cell motility?

Detalles Bibliográficos
Autores principales:	Giampieri, S, Sahai, E
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2006
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3300291/ http://dx.doi.org/10.1186/bcr1599

Ejemplares similares

Activation of TGF-beta signalling in breast cancer metastatic cells
por: Giampieri, S, et al.
Publicado: (2008)

Association of gene variants in the transforming growth factor beta signalling pathways with invasive breast cancer risk
por: Scollen, S, et al.
Publicado: (2006)

Development of small-molecule transforming growth factor beta antagonists
por: Warner, DJ, et al.
Publicado: (2006)

Colorectal cancer patients show decrease in cellular immunity and enhanced plasma level of transforming growth factor – beta and vascular endothelial growth factor (VEGF)
por: Zavadova, Eva, et al.
Publicado: (2013)

Epigenetic silencing of tropomyosin alters transforming growth factor beta control of cell invasion and metastasis
por: Bakin, A, et al.
Publicado: (2005)

Transforming growth factor beta 1 gene transcription in infection and severe sepsis displays distinguishing characteristics
por: White, M, et al.
Publicado: (2008)

Localised and reversible TGFβ signalling switches breast cancer cells from cohesive to single cell motility
por: Giampieri, Silvia, et al.
Publicado: (2009)

Targeting transforming growth factor beta signaling in metastatic osteosarcoma
por: Ge, Rongrong, et al.
Publicado: (2023)

Laminin type 1 augments the transforming growth factor beta-induced expression of matrix metalloproteinase 3 in synovial fibroblasts
por: Hoberg, M, et al.
Publicado: (2005)

440 Novel mechanism of transforming growth factor beta-1 signaling in human bronchial epithelia
por: Donovan, J., et al.
Publicado: (2022)

Transforming growth factor-beta co-receptor endoglin suppresses breast cancer invasion and metastasis
por: Henry, LA, et al.
Publicado: (2010)

Insulin-like growth factor signalling in oestrogen nonresponsive breast cancer cells
por: de Blaquiere, GE, et al.
Publicado: (2006)

Attachment of synovial fibroblasts to type 1 laminin boosts the transforming growth factor beta-induced expression of stromelysin-1 (MMP-3)
por: Aicher, WK
Publicado: (2004)

Association of gene variants in the TGF-beta signalling pathways with invasive breast cancer risk
por: Scollen, S, et al.
Publicado: (2008)

Insights into the role of Notch signalling in cilia motility regulation
por: Sampaio, P, et al.
Publicado: (2015)

Metabolic transformations in breast cancer subtypes
por: Mitra, Devina, et al.
Publicado: (2014)

Transforming growth factor beta (TGFβ) signaling is regulated at the pocket region of primary cilia
por: Christensen, S, et al.
Publicado: (2012)

Activation of synovial fibroblasts by laminin-1 and transforming growth factor beta induces expression of stromelysins independently of TNFα, IL-1β or NF-κB
por: Warstat, Katrin, et al.
Publicado: (2007)

Use of mouse models to validate and therapeutically target transforming growth factor beta as an important player in breast cancer progression
por: Wakefield, LM, et al.
Publicado: (2003)

Transforming growth factor beta isoforms in breast cancer.
por: Benson, J. R., et al.
Publicado: (1994)

Transforming Growth Factor Beta Signaling in Dendritic Cells Is Required for Immunotolerance to Sperm in the Epididymis
por: Pierucci-Alves, Fernando, et al.
Publicado: (2018)

Progress towards unlocking the secrets of oestrogen receptor beta in breast cancer
por: Speirs, V, et al.
Publicado: (2006)

Ezrin is required for adhesion and migration in invasive breast cancer
por: Szeto, Alvin, et al.
Publicado: (2013)

Suppression of the NF-κB co-factor, Bcl3, delays the metastatic progression of breast cancer
por: Wakefield, AM, et al.
Publicado: (2010)

MDM2-dependent inhibition of P53 is required for Epstein-Barr virus B cell growth transformation and infected cell survival
por: Forte, E, et al.
Publicado: (2009)

Transforming Growth Factor Beta3 is Required for Cardiovascular Development
por: Chakrabarti, Mrinmay, et al.
Publicado: (2020)

Role of the Hsp90 cochaperone, FKBPL, in oestrogen receptor signalling and breast cancer growth and survival
por: McKeen, H, et al.
Publicado: (2008)

Gefitinib in treatment of metastatic non-small cell lung cancer (NSCLC) with mutated epidermal growth factor receptor (EGFR)
por: Singh, Charu
Publicado: (2014)

Synergy between the erbB and transforming growth factor beta signaling networks: implications for molecular therapeutics in human neoplasia
por: Arteaga, CL
Publicado: (2003)

A computational approach to dendritic spine motility with calcium signaling by the immersed boundary method with advection-electrodiffusion
por: Lee, Pilhwa, et al.
Publicado: (2007)

The Transcription Factors Snail and Slug Activate the Transforming Growth Factor-Beta Signaling Pathway in Breast Cancer
por: Dhasarathy, Archana, et al.
Publicado: (2011)

The role of neopterin in patients with primary and metastatic breast cancer: correlation with clinicopathological data
por: Demian, Soheir Rizk, et al.
Publicado: (2014)

Circulating epithelial tumor cells in patients with metastatic breast cancer treated with bevacizumab
por: Manso, L, et al.
Publicado: (2009)

Phosphoinositide 3-kinase class II beta is a novel target in breast cancer therapy
por: Abbott, J, et al.
Publicado: (2010)

Investigating the effects of beta-amyloid on hippocampal signalling in Alzheimer's disease
por: Warburton, Julia M, et al.
Publicado: (2015)

A modeling study on the signal transformation for the microsaccade generation
por: Inagaki, Keiichiro, et al.
Publicado: (2010)

Discovery and characterization of an immunogenic neoantigen in a patient with metastatic triple negative breast cancer
por: Assadipour, Yasmine, et al.
Publicado: (2015)

Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study
por: Amir, E, et al.
Publicado: (2009)

Regulation of estrogen receptor beta by 5' untranslated regions in breast carcinogenesis
por: Smith, L, et al.
Publicado: (2008)

Insulin-like growth factor binding protein-2 alters the sensitivity of breast cancer cells to chemotherapy
por: Foulstone, EJ, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_2897r1eio8520ecm0s28ev9iab